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Abstract 
In intracardiac impedance, electrical bio-impedance is measured inside 
the heart. This signal is known to reflect the volume of blood passing in and 
out of the ventricles. In transthoracic impedance the measurement current and 
voltage sensing is connected on the subject’s chest. In this thesis, the 
intracardiac impedance is studied in general, and in the filling phase (diastole) 
in particular. The diastolic intracardiac impedance displays a consistent slope 
change (notch). The notch in the present thesis has similar features as the non-
invasive transthoracic impedance O-wave reported earlier. The notch 
occurrence was found to be well comparable with results in work with O-wave. 
The notch was found closely after early rapid ventricular filling but before 
ventricular filling caused by atrial contraction and it is concluded that the notch 
is not caused by atrial contraction. The notch is most likely caused by cardiac 
wall movements in rapid ventricular filling. The observations in this thesis are 
made in two different data sets; in animals and in humans and with different 
types of intracardiac leads. The lead implantations were performed by several 
different physicians. With the consistent results from these two studies at hand, 
this licentiate thesis concludes that the diastolic intracardiac impedance notch 
is a characteristic of intracardiac impedance, that the notch is the intracardiac 
equivalent of the non-invasive transthoracic impedance O-wave and that it is a 
sensed physiological cardiac parameter of diastole. Since the present data is 
measured intracardically it can be concluded that the non-invasive O-wave in 
fact is caused by cardiac movements.  
Keywords:  intracardiac impedance, O-wave, diastole, pacing 
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1 Introduction  
1.1 The heart 
In awake and resting humans, the heart beats approximately once every 
second. The heart rate is then said to be 60 beats per minute (bpm). Normally, 
the electrical activity of specialized cells in the sinus node is conducted 
throughout the cardiac conduction pathways inducing cardiac contractions in a 
frequent manner thus controlling the heart rate (HR, [bpm]). When the sinus 
node is controlling the heart rate, the heart is in a so-called sinus rhythm. When 
needed, the heart rate of a healthy heart can be increased dramatically through 
different physiological controlling mechanisms. The cardiac electrical 
activation pattern can be studied in the electrocardiogram, ECG, measured 
through electrodes placed on the subject’s skin. The electrical activity can also 
be measured inside the heart with electrodes placed in the cardiac tissue 
(myocardium). The electrical activation pattern measured from inside the heart 
is called intracardiac electrogram, IEGM. Clinically the ECG is used for 
diagnostic purposes (such as myocardial infarction) and not the IEGM since 
the latter electrogram only registers the local electrical activity surrounding the 
intracardiac electrode. 
If the cardiac conduction pathways are disrupted, the heart rate is often 
reduced (bradycardia) and the heart lacks ability to increase the pumping 
frequency and is therefore incapable to respond properly to physical demand. 
In addition, the heart rate in resting conditions is often too low. The 
2 Introduction 
 
bradycardia patient is unable to live a normal life and needs a pacemaker 
system to maintain adequate heart rate (DAS and CARLBLOM, 1990). A 
pacemaker system consists of a pulse generator and one or two pacemaker 
leads and is normally implanted during local anesthesia. The tips of the leads 
are normally placed inside the heart as the leads are introduced through the 
venous blood vessels. The pulse generator is placed under the skin 
(subcutaneously).  
 
 
 
 
 
 
 
 
Figure 1.1 A pacemaker system in a patient. 
The pacemaker system causes cardiac contraction as the pulse generator 
emits stimulation pulses to the cardiac tissue through the intravenous 
pacemaker leads. Modern pacemakers do not only maintain a basic heart rate 
by fixed rate stimulation. These systems are also designed to mimic the 
physiological heart rate behavior during physical load by controlling the 
stimulation rate with different types of sensors (ALT et al., 1998; KARLÖF, 
1974; LAU, 1992; NAPHOLZ et al., 1987; 1990; SCHALDACH et al., 1992;). So 
far, the over-all ambition has been to avoid sensors that would complicate the 
otherwise robust and standardized leads. 
During every normal heartbeat, a volume of blood is ejected to all the 
organs of the body (stroke volume SV, [ml]). Normally this specific volume of 
blood is transported to the lungs (lesser or pulmonary circulation) and later 
thorax
heart
pacemaker lead
pulse generator
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routed to the rest of the body (body or systemic circulation). When the blood is 
passed through the pulmonary circulation, the blood oxygen content is 
increased and blood carbon dioxide content is decreased through a gas 
exchange process in the lungs. The heart has four chambers (two atria and two 
ventricles) organized in two pumps. Right atrium and right ventricle is the 
pump for the pulmonary circulation whereas left atrium and left ventricle is the 
pump for the systemic circulation (RHOADES and TANNER, 1995). Four valves 
are positioned inside the heart making sure that blood flow is unidirectional.  
 
 
 
 
 
 
 
 
Figure 1.2 The anatomy of the heart. 
pulmonalic valve 
right atrium 
tricuspid valve 
right ventricle 
left atrium
aortic valve
mitralis valve
left ventricle
aorta
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Since these two pumping units are connected one after the other (in 
series) it is important that each pump ejects the exact same amount of blood 
over a period of time. If not, an unbalanced distribution of blood volume 
between the pulmonary and systemic circulation will occur causing volume 
overload (edema).  
1.2 Diastole 
Every heartbeat has a filling phase (diastole) and an ejection phase 
(systole), Figure 1.3. During diastole, the heart muscle relaxes, mitral and 
tricuspid valves between the atria and the ventricles (situated in atrio-
ventricular plane, AV-plane) open and the ventricles are passively filled with 
blood – rapidly at first in the rapid filling phase, and then slowly in the slow 
filling phase. When the slow filling phase has ended, the ventricles are filled 
with some additional blood as the atria contract. 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 The filling phases of the cardiac cycle as seen in schematically drawn curves 
of ventricular volume and pressure, together with ECG. In the ventricular pressure 
curves, the maximum (#) and minimum (£) slope of pressure is marked (maximum and 
minimum value of first derivative of pressure). These points in the heart cycle may serve 
as good indicators for opening and closing of valves respectively (see text). 
ventricular 
volume 
ECG 
P 
Q 
R 
S 
T P 
Q 
R 
S 
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ventricular 
pressure 
rapid slow 
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Introduction 5 
1.3 Echocardiography 
A number of cardiac characteristics can be studied and evaluated by 
using echocardiography. In echocardiographical measurements, ultrasonic 
waves are transmitted to the subject (HATLE, 1986; 1987), and as the internal 
cardiac structures reflect these waves, live images of the working heart can be 
created and studied. Cardiac wall movements and blood flow patterns can be 
calculated and studied using the echocardiographical images. A common 
clinical way of determining filling characteristics in patients is to evaluate the 
blood flow pattern between atrium and ventricle in diastole, as seen in mitral 
and tricuspid valve blood flow, Figure 1.4.  
 
 
 
 
Figure 1.4 Schematic picture of echocardiographical measurements of AV-plane valve 
blood flow pattern.(in this example, right ventricle is displayed in echocardiographical 
“window”) 
As described earlier, the filling phase can be divided into rapid or early 
filling and slow filling. Rapid early ventricular filling is displayed as a large 
peak E in mitral or tricuspid blood flow, and ventricular filling caused by atrial 
contraction is displayed as a smaller peak A. 
1.4 Impedance 
When a voltage source is connected to a conducting material, 
movement of free electrons of the material achieves an electrical current. As 
the voltage source has a positive and negative pole connected to the material in 
question, the free negatively charged electrons are attracted to the positive pole 
E 
A A 
E 
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and therefore tend to move in that direction. The properties of the achieved 
electrical current depend on the conducting characteristics of the material and 
also on the characteristics of the voltage signal. When the material is said to be 
purely resistive, the current level is independent on voltage frequency. The 
higher resistance (R, Ohm) the lower the resulting current (I, Amperes A) for a 
given voltage (U, Volt). This can be expressed in a reversed way; when a 
current source with current I (A) is applied to a conducting material with the 
resistance R (Ohm), a resulting voltage drop U (V) can be measured across the 
material, Figure 1.5.  
 
 
 
 
 
Figure 1.5 A current I is applied on the subject through two electrodes and the resulting 
voltage U is measured between another pair of electrodes in a so-called four-pole 
configuration 
The voltage U can be calculated with the Ohm’s law: 
 
 
Figure 1.6 Ohm’s law 
However, if the material is composed of non-resistance components 
such as capacitors or inductors, the material is no longer resistive and 
frequency dependency is introduced. Ohm’s law still applies, although 
resistance R is replaced with impedance Z (Ohm) in the formula. The 
impedance of a capacitor C is dependent on the frequency of the applied 
current or voltage source and the capacitor’s capacitance, 
I 
+ 
- 
U 
U=R*I 
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f, frequency (Hz); C capacitance (farad, F) 
 
This means that the higher frequency, the lower impedance and vice 
versa. 
Electrically, the cell membrane acts like a capacitor. In biological 
material the conduction is essentially ionic, i.e. the current is caused by 
movement of ions that are much bigger and heavier and have less mobility that 
electrons. If a measuring current of a very low frequency is applied over a 
biomaterial composed of many cells, the current is mainly conducted through 
the fluid surrounding the cells because it is blocked to pass through the cell 
membrane. On the other hand, if a high frequency measuring current is applied 
it would conduct through the cell membrane to the interior of the cell and thus 
revealing the electrical properties of the internal cell structures.  
1 
2πfC 
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Figure 1.7 Measurement current is conducted through biomaterial in different way 
depending on frequency 
A; schematic picture of a cell with cell membrane and internal cell structure 
B; low frequency current is conducted through extracellular tissue space 
C; high frequency current is coupled capacitively through the cell membrane and into 
the internal cell structures (intracellular tissue) 
By applying measurement current and changing the current frequency 
over a wide range, and registering the voltage response, electrical 
bioimpedance can be measured and different layers, components or organs of 
the biomaterial can be studied. (FOSTER and SCHWAN, 1989, GABRIEL et al., 
1996, ZHAO, 1993). In fact, different changes in for instance human skin can be 
detected much earlier compared to conventional methods by using electrical 
impedance (NICANDER, 1998). In electrical impedance tomography (EIT), 
internal organs can be imaged (BOONE et al., 1997). In general, the impedance 
of cardiac tissue is higher compared to the impedance of blood, i.e. electrical 
current is more easily conducted through blood. In other words, the 
conductivity of blood is higher compared to the conductivity of cardiac tissue.  
In invasive impedance the measurement is performed using the 
electrodes placed inside the subject (see 1.4.1 on page 9). By applying 
cell 
cell 
membrane 
A B C 
Introduction 9 
measuring current and sensing resulting voltage from electrodes positioned on 
the subject’s skin, non-invasive impedance is obtained (see 1.4.4 on page 12). 
1.4.1 Invasive intracardiac impedance 
Invasive impedance in general is measured from inside the body. 
Intracardiac impedance measurements are performed locally inside the heart 
and are therefor invasive. Intracardiac impedance measured through pacemaker 
leads reflects ventricular volume and can be used as a sensor signal, see Figure 
1.8. 
 
 
 
 
 
 
 
Figure 1.8 ECG and impedance signal measured in sheep with a standard bipolar 
pacing lead in right ventricular apex. Measurement current: 10μA, 4kHz square wave. 
The intracardiac impedance signal in Figure 1.8, is in this example 
presented as the voltage between tip and ring of a standard bipolar pacing lead 
in right ventricular apex (a square-wave measuring current is connected to the 
same pair of electrodes). During systole, the intracardiac impedance increases 
rapidly as a result of the ejection of blood. The impedance slope in this interval 
can represent the level of contraction force, contractility (see tilted dotted line 
in impedance signal in figure above). At end-systole, when blood has been 
ejected, the lead tip is surrounded by myocardial tissue, although there is a 
residual volume of blood remaining in the ventricles. The relatively high 
P QRS T 
current 
voltage tip 
ring 
pacemaker 
lead 
[V] 
[V] 
EJECTION FILLING 
volume 
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impedance of the myocardium is dominating the resulting impedance at this 
point, thus causing the maximum impedance in the intracardiac impedance 
curve. As the ventricles are filled with blood in diastole, the impedance is 
decreased. Maximum ventricular volume is present after atrial contraction. At 
this point, in end-diastole just prior to ventricular contraction, the intracardiac 
impedance is at its lowest point, since the measuring electrodes are surrounded 
with blood with higher conductivity. At this point intracardiac impedance has 
reached a low value corresponding to ventricular end-diastolic volume.  
1.4.2 Intracardiac impedance configurations in pacemaker 
systems 
With a pacemaker system consisting of a standard bipolar pacemaker 
lead in right ventricle and a subcutaneously placed pulse generator, there are 
three electrodes at hand for impedance measurements. The measurement 
current and measurement voltage can be applied in 9 different ways: 
 Measurement current Measurement voltage 
1.  tip-ring tip-ring 
2.  tip-ring tip-indifferent 
3.  tip-ring ring-indifferent 
4.  tip-indifferent tip-ring 
5.  tip-indifferent tip-indifferent 
6.  tip-indifferent ring-indifferent 
7.  ring-indifferent tip-ring 
8.  ring-indifferent tip-indifferent 
9.  ring-indifferent ring-indifferent 
Table 1. In an implantable pacemaker system with one bipolar pacemaker lead and 
pulse generator capsule, 9 different impedance configurations are available. 
In this thesis, the only configuration that has been studied is the first 
configuration; i.e. measuring current applied between tip and ring of a standard 
bipolar pacemaker lead in right ventricular apex and the sensing voltage 
between the same pair of electrodes. 
The measured voltage is modulated both by cardiac events and by 
thoracic movements caused by respiration. Applying the measuring current 
indifferent 
tip 
ring 
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and/or sensing the voltage over the thoracic cavity (e.g. the indifferent 
electrode is used) will increase the level of respiratory modulation of the 
resulting impedance signal. On the other hand, by performing the impedance 
measurements between the tip and ring, the impedance is mainly reflecting 
cardiac activity. 
1.4.3 Intracardiac impedance as sensor 
As previously mentioned, modern pacemaker systems are designed to 
maintain the heart rate in a physiological way by measuring physiological 
parameters for stimulation control. A pacemaker system does not require any 
specialized leads or sensors to measure intracardiac impedance. The 
intracardiac impedance is generated and processed by pulse generator 
electronics using the available pacemaker lead electrodes and pulse generator 
capsule. Because of this important advantage, and the need for physiological 
stimulation control, all major pacemaker manufacturers have pacemaker 
models using impedance in some way: respiration controlled pacemaker (ALT 
et al., 1998; NAPHOLZ et al., 1987; 1990) and contractility controlled 
pacemaker (SCHALDACH et al., 1992).  
Some applications measure stroke volume using left ventricular 
conductance measured with the multi-electrode “Baan” catheter temporarily 
positioned in left ventricle (BAAN et al., 1984). This technique has also been 
studied in the right ventricle (STAMATO et al., 1995). The conductance catheter 
technique requires calibration steps where the conductance of blood is 
measured and also where the “parallel conductance” is registered. The parallel 
conductance is a correction term caused by the structures surrounding the 
ventricular cavity. The calibration steps are necessary in order to get absolute 
values of ventricular volume. Since these calibration steps are not possible in 
implantable devices, only relative measurements of volume are possible in 
pacemaker systems. Although studies using stroke volume for stimulation rate 
control have been performed (SALO et al., 1984; CHIRIFE, 1991; CHIRIFE et al., 
1993) no such pacemaker systems are commercially available at the present 
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time. Absolute values of volume may be very difficult to measure, if at all 
possible, although some non-invasive instruments are available on the market. 
1.4.4 Non-invasive transthoracic impedance 
Non-invasive transthoracic impedance measurement system are 
developed and described by others (KUBICEK et al., 1966; 1974). In this setup, 
four band electrodes are placed around the neck and abdomen of the subject, 
Figure 1.. The measuring current is connected to the outer band electrodes and 
the resulting voltage is sensed from the two inner band electrodes. With this 
system non-invasive transthoracic impedance is registered.  
 
 
 
 
 
 
Figure 1.9 Electrode placement for non-invasive transthoracic impedance 
measurements (see text) 
Numerous studies have analyzed how the transthoracic impedance can 
be used to measure stroke volume and cardiac output (CO, stroke volume x 
heart rate, [l/min]) (KUBICEK et al., 1966; 1974, MUZI et al., 1985, DONOVAN 
et al., 1986). The time relation between transthoracic impedance, ECG and 
cardiac time intervals is mainly studied using the first derivative of the 
transthoracic impedance cardiogram, dZ/dt (LABABIDI, 1978, KUBICEK et al., 
1974; KARNEGIS and KUBICEK, 1970). Lababidi et al. did a thorough definition 
of all curve segments in the first derivative of non-invasive transthoracic 
impedance cardiogram (dZ/dt) and its relation to phonocardiography 
i u 
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(LABABIDI et al., 1970). In fact, most of the impedance cardiogram work refers 
to this particular document for interpretation of transthoracic impedance curve 
segments. (In phonocardiography, sounds of valve closure “snaps” and blood 
flow pattern are registered and studied.) Studies have shown that the dZ/dt can 
be used to measure a number of important hemodynamic properties. In the 
diastolic dZ/dt there is a so called O-wave coinciding with mitral valve opening 
seen in apex cardiogram (LABABIDI, 1978; RAMOS, 1977), Figure 1.10. Apex 
cardiogram is the pressure pulsation caused by cardiac contractions in the apex 
area measured on the subject’s chest. 
14 Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10 First derivative of transthoracic impedance, phonocardiography and apex 
cardiogram (schematically redrawn after LABABIDI et al., 1970 and PREWITT et al., 
1975). 
The transthoracic impedance O-wave is more dominating in patients 
with impaired cardiac function and is increased in size in patients with mitral 
valve leakage (regurgitation), volume overload and increased left atrial 
pressure. (SHOEMAKER et al., 1994; KARNEGIS et al., 1981; HUBBARD et al., 
1986; WOLTJER et al., 1997; ALT et al., 1998; PICKET and BUELL, 1993; MUZI 
et al., 1985).  
The transthoracic impedance is interpreted to contain impedance data 
originating from the heart. However, studies have showed that the so called 
O 
Z 
B 
first derivative of 
transthoracic impedance 
phonocardiography 
S1 S2 S3 
apex cardiogram 
O 
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cardiac signal in the non-invasive impedance signal also can be retrieved from 
measurements performed on for example an arm (KAUPPINEN, 1999). The 
reason for this is that pulsations caused by cardiac contractions are transmitted 
to the body tissue of the arm. Therefore, the true explanation for cardiac signal 
in transthoracic impedance, and therefore also the O-wave, is complex and not 
straightforward.  
1.5 Thesis outline 
In intracardiac impedance measurements performed in research projects 
at St Jude Medical AB, a small slope change in the diastolic phase was visually 
observed. These initial findings were made in measurements in animal subjects 
(pre-clinical measurements) and are analyzed and reported in paper I. In order 
to see if this slope change (notch) also can be observed in measurements in 
humans (clinical measurements), intracardiac measurements made in a human 
study were analyzed and reported in paper II.  
1.5.1 Purpose and goals of the thesis 
The purpose and goals of this thesis are in general to describe and 
analyze diastolic intracardiac impedance, and specifically to describe, analyze 
and explain a specific diastolic intracardiac impedance waveform called notch. 
One hypothesis for the notch is that it may be caused by a ventricular 
wall movement generated by the change from rapid blood inflow to slow blood 
inflow associated with diastole going from rapid filling to slow filling. This 
Ph.D. work is aimed to explain the mechanisms behind this impedance 
behavior. 
The purpose of the present thesis was also to find out if the intracardiac 
impedance contains a similar O-wave as in the non-invasive impedance, which 
would strongly suggest that non-invasive O-wave originates from the heart. 
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2 Methods and materials  
2.1 General 
This thesis is based on two studies described below (paper I and paper 
II). All impedance measurements have been performed with the same 
impedance equipment described below. The basic principle for data collection 
is the same in both studies. The signal analysis in these two studies have been 
performed using the same methodology. 
2.2 Data collection 
In both studies, several signals were recorded digitally on DAT tapes 
(RD-145T 16 channel DAT tape recorder, DC-5 kHz, anti-aliasing filter, 
TEAC America, Inc.). The anti-aliasing filter is used to prevent the registered 
data to be disturbed by signals containing frequencies above 5 kHz. In paper I, 
the data was also simultaneously stored on computer hard disk at the time of 
the test (250 Hz or 500 Hz sampling frequency, special binary file format, 
WINDAQ software, DATAQ Instruments, Inc.). In paper II, the data on DAT 
tapes were transferred to WINDAQ binary files at a later point, with a 
sampling frequency of 1 kHz. 
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2.3 Signal analysis 
Typically 10-30 heart cycles of sinus rhythm signals of specific time 
segments were transferred to PC calculating program called MATLAB (The 
MathWorks, Inc.) for calculation of “averaged heart cycle appearance”. This 
was done to study typical signal appearance of one heart cycle, Figure 2.1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 The methodology by which “averaged heart cycle signal” is calculated is 
described. In this example 8 heart cycles were identified to be analyzed, an ASCII file 
with these cycles were cut out from original WinDaq file and used in Matlab tool for 
further analysis. 
In the selected data of signals, all ECG R-waves were detected and thus 
all available heart intervals were identified. For each sample in the ensemble of 
signal data, both average and standard deviation value were calculated, thus 
all found heart intervals 
Averaged heart cycle appearance 
All interesting signals are averaged 
standard deviation is also calculated 
1 
time 
2 
8 
original 
file 
selected 
data 
1               2          3          4          5         6           7         8 
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forming an averaged curve form (KELSEY and GUETHLEIN, 1990; MUZI et al., 
1985) together with standard deviation curve form over one heart cycle. First 
derivative of impedance was calculated in MATLAB using the “gradient” 
function. This derivative impedance signal was then low pass filtered with a 
cut off frequency of 50 Hz in paper I and 35 Hz in paper II (4th order 
Butterworth low-pass filter, zero-phase filtering), forming the derivative signal 
presented here.  
2.4 AC impedance 
All impedance measurements performed in this thesis have been 
performed using the same impedance equipment described below. 
The AC-impedance equipment is designed and built at St Jude Medical 
AB. The right ventricular impedance signal in the present thesis was measured 
as the voltage difference between tip and ring on the lead positioned in the 
right ventricular apex, with measurement current applied between the same 
electrodes Figure 2.2.  
 
 
 
 
 
Figure 2.2 Block diagram for the AC impedance box. 
The current generator generates a 4 kHz square wave measurement 
current. The choice of frequency was made due to the fact that pacemakers at 
that time of design had a 32 kHz crystal frequency and telemetry at 4 kHz, and 
the circuitry design was aimed to fit the reality of pacemaker technology. The 
current 
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blood impedance is also mainly resistive at this frequency (GABRIEL et al., 
1996; FOSTER and SCHWAN, 1989) and higher frequencies would drain 
pacemaker battery too much.  
The voltage response signal is amplified 500 times in an isolation 
amplifier with isolation barrier of at least 3.5 kV. The synchronous 
demodulator samples every half wave of the square wave response signal and 
negative samples are inverted. All samples are added up resulting in an 
impedance signal with a band width of 0-180 Hz. The output isolation 
amplifier (isolation barrier 2.5 kV) adjusts the output level to establish a volt-
to-ohm relation. The demodulator is also connected to a pace pulse detector 
that considers a sensed impedance level above 900 ohms as a detected 
stimulation pulse. When a stimulation pulse is detected the pace pulse detector 
returns a blank signal to the demodulator that turns the demodulation off for 40 
ms. This minimizes disturbances from the stimulation pulse on the impedance 
signal. 
2.5 Pre-clinical study, Paper I 
Impedance data from 9 animals over a period of 2 years (1996-1997) 
were analyzed. The procedure in anesthesia, pacemaker lead type, protocol and 
impedance measurement equipment were similar in all experiments. All 
catheters and leads were implanted transvenously. The pacemaker lead type 
used was a standard bipolar, MEMBRANE 1401T, Pacesetter, Inc. In order to 
ensure anesthesia stability, manual notes of heart rate, blood pressure, blood 
temperature and blood gas sample results were made continuously throughout 
each test. As discussed in paper I , transesophageal echocardiography 
measurements were performed together with similar signals as described above 
in an additional animal subject. (In transesophageal echocardiography, the 
probe is positioned inside esophagus producing a much clearer image 
compared to regular echocardiography with the probe positioned on the 
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subject’s chest.) The procedure in anesthesia, protocol and pacemaker lead type 
was similar to the other 9 tests. 
2.6 Clinical study, Paper II 
Intracardiac impedance data was measured in 20 patients during the 
observational period following a catheter ablation in an electrophysiological 
procedure (EP). In an EP procedure, awake patients with unnormal cardiac 
conduction pathways (that may cause heart palpitations with a too high heart 
rate) are examined during local anesthesia. The pathological pathways are 
localized by temporarily positioning several intracardiac multielectrodes in the 
cardiac tissue region of interest. The small area in the cardiac tissue that causes 
the arrhythmia is then destroyed (ablated) by high frequency current causing a 
high temperature locally. After ablation, there is an observational period where 
the patient is normally in sinus rhythm, after which the ablation success is 
verified. All patients enrolled for this study had sinus rhythm during the 
impedance measurements. All measurements were performed with a standard 
four-polar EP catheter (standard quadripolar EP-catheter USCI, C.R. Bard Inc., 
New Jersey, USA). The 20 patients were divided into two groups. In one group 
of 10 patients the impedance was measured at rest during five minutes from 
three different pairs of electrodes: a) electrodes 1 (distal, in apex) and 2 (10 
mm inter-electrode distance), b) electrodes 1 and 3 (20 mm) and c) electrodes 1 
and 4 (30 mm), Figure 2.3 
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Figure 2.3 Impedance configuration in clinical study (paper II). The measurement 
current is applied between EP catheter electrodes 1 and 2. The resulting voltage is 
sensed between electrodes 1 and 2, or between 1 and 3 or between 1 and 4 (see text). 
In the second group of 10 patients, the impedance was measured 
between two different pairs of electrodes at rest and was thereafter repeated 
during drug induced increase of cardiac workload. The measurements were 
performed between electrodes 1 and 2 (10 mm inter-electrode distance) and 1 
and 3 (20 mm). An increase in the cardiac workload was achieved with an 
infusion of isoproterenol (2 μmol/ml) which was titrated to obtain a heart rate 
of 110-120 bpm. Measurements were started when a stable heart rate had been 
established. 
 
 
right atrium
EP catheter 
apex 
left atrium 
left ventricle 
right ventricle
1
2
3
4
 23 
 
3 Results 
3.1 General 
All impedance measurements reported in paper I and paper II were 
made during sinus rhythm. 
3.2 Paper I, pre-clinical study 
Intracardiac impedance signals from 9 animals (7 sheep and 2 dogs) 
under general anesthesia were analyzed.  
The impedance signal shape varies remarkably from one individual to 
another, although the main shape with the lowest point close to R-wave in ECG 
and highest point close to end of T-wave still remains (with one exception 
described in detail in Paper I). The averaged impedance curve form in sheep is 
displayed in Figure 3.1.  
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Figure 3.1 Example of intracardiac impedance signal (The top graph displays averaged 
intracardiac impedance (black curve) together with ECG, left ventricular pressure 
(LVP) and right ventricular pressure (RVP). The bottom graph displays averaged heart 
cycle curve of first derivative of intracardiac impedance. (Heart cycle averaged signals 
using 18 sinus rhythm heartbeats in sheep. Average heart rate=77.0 ± 0.5 bpm, average 
impedance=607.5 ± 52.0 Ω.) 
In 8 of first 9 animal subjects (89%), a visible and consistent impedance 
slope change (notch) was visually observed in the early cardiac filling phase 
(Figure 3.1). The notch position is taken as the point at which the impedance 
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slope changes in the diastolic phase. In the first derivative of intracardiac 
impedance the notch can be detected as the first zero-crossing after maximum 
in the original impedance. In the additional measurement (10th animal) with 
simultaneous echocardiographical measurements of mitral blood flow, a notch 
was visually observed similar to the other experiments. As displayed in Figure 
3.2 it occurs shortly after rapid filling as seen as E-wave, but prior to (left) 
ventricular filling caused by (left) atrial contraction (A-wave). 
 
 
 
 
 
 
 
Figure 3.2 Echocardiographical measurements performed simultaneously with 
intracardiac impedance in sheep. The results from mitral blood flow and tricuspid AV-
plane movement measurements are aligned for analysis purposes. An impedance notch 
is visually observed after rapid ventricular filling (E) but before ventricular filling 
caused by atrial contraction (A). 
As the intracardiac impedance is measured on the right side, tricuspid 
valve operation may have some influence on notch and was therefore 
investigated further in the 10th animal. In Figure 3.2, the movements of the 
tricuspid AV-plane is somewhat unclear at the time of the notch. As described 
earlier, a good marker for detection of tricuspid and mitral valve opening is the 
minimum of first derivative of right and left ventricular pressure respectively. 
In order to further indicate when the tricuspid and mitral valves open, first 
derivative for right and left ventricular pressures were calculated and minimum 
peaks of these signals were detected for each heart cycle in all 10 animals. 
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These peaks can be viewed as time points where tricuspid valve and mitral 
valve open, see Figure 3.3 (same animal as in Figure 3.1). For each heart cycle, 
the time difference between these two peaks was calculated, estimating the 
time difference between opening of tricuspid and mitral valve.  
 
 
 
 
 
 
 
 
 
 
Figure 3.3 From the top: ECG, left ventricular pressure (LVP, black curve), right 
ventricular pressure (RVP, gray curve), first derivative of pressures and intracardiac 
impedance. Time difference is calculated as the time difference between the minima of 
first derivatives of pressures. For this particular animal, minimum of first derivative of 
RVP occurs 36 ms before minimum of first derivative of LVP. 
In one animal, no data of left ventricular pressure were available. In 7 
of the remaining 9 animals, the minimum of first derivative of right ventricular 
pressure occurred 23.6 ms (standard deviation 24.4 ms) before minimum of 
first derivative of left ventricular pressure. This result suggests that tricuspid 
valve opens 23.6 ms before mitral valve. 
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3.3 Paper II, clinical study 
With two exceptions, mean impedance was increased during drug 
induced work load in the second group. The impedance signal shape varied 
remarkably from one individual to another, although the main shape with the 
lowest point close to R-wave in the ECG and highest point close to end of T-
wave still remained. In Figure 3.4, an example of right ventricular impedance 
in a healthy patient with normal cardiac function at rest condition is displayed.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Example of intracardiac impedance signal in a healthy patient. The top 
graph displays averaged intracardiac impedance, the middle graph displays averaged 
heart cycle curve of first derivative of intracardiac impedance and the bottom graph is 
the normalized ECG. Heart cycle averaged signals using 18 sinus rhythm heartbeats in 
sheep. Average heart rate=77.0 ± 0.5 bpm, average impedance=607.5 ± 52.0 Ω.) 
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The notch is defined as the first positive slope change in the negative 
diastolic impedance slope between end of T-wave and P-wave in the ECG, 
Figure 3.5. 
 
 
 
 
 
 
Figure 3.5 Definition of intracardiac diastolic notch: the first positive slope change in 
the negative diastolic impedance slope between end of T-wave and P-wave in the ECG. 
A slope change immediately at the end of T-wave is not considered to be an observed 
notch. 
In 80% or more of the patients (depending of the inter-electrode 
distance and group), the notch was observed in early cardiac filling phase (see 
ring mark in Figure 3.4). In Table 2 below, the notch occurrence is presented in 
more detail. 
Number of patients and impedance configurations in each visible notch in 
10 mm distance tip-ring (20 patients) 90% (18 of 20 patients) 
20 mm distance tip-ring (20 patients) 100% (20 of 20 patients) 
30 mm distance tip-ring (10 patients) 90% (9 of 10 patients) 
10 mm distance tip-ring, isoproterenol (10 patients) 80% (8 of 10 patients) 
20 mm distance tip-ring, isoproterenol (10 patients) 80% (8 of 10 patients) 
Table 2. Notch occurrence in paper II. Depending on tip-ring distance and group, the 
notch occurrence varies between 80-100 %. 
T P 
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In order to investigate how the notch was affected by heart rate, the 
time between the R-wave in the ECG and the notch is plotted versus heart rate. 
The R-to-notch time is normalized with regards to average heart cycle interval. 
As shown in paper II, the R-notch time varies exponentially with heart rate 
(r2=0.95). 
3.4 Summary of results 
The signal analysis creating averaged curve forms and standard 
deviation curve forms present the data conveniently. In both studies, a slope 
change in diastolic intracardiac impedance was visually and consistently 
observed. The slope change, notch, is seen in 9 of 10 animals (90%) in paper I 
and in over 80% of the patients in paper II. In some cases the notch produced a 
large bump in diastolic impedance, whereas in other cases the notch only 
produced a small change in intracardiac impedance slope. In one animal 
subject (paper I), echocardiographical measurements of mitral blood flow 
performed simultaneously with intracardiac impedance measurements showed 
that the notch occurred after rapid ventricular filling E but before ventricular 
filling caused by atrial contraction A. In the human data in paper II, the R-
notch time varies exponentially with heart rate (r2=0.95). 
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4 Ethical approval 
The ethic approvals are found in the appendix. 
4.1 Paper I, pre-clinical study 
The local Ethics Committee has approved the animal measurements. 
All animals received human care in compliance with the European Convention 
on Animal Care.  
4.2 Paper II, clinical study 
The Hospital’s Human Ethics Committee approved the research 
protocol and all patients gave written informed consent prior to the test. 
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5 Discussion 
5.1 Polarization 
If the current injecting electrodes and voltage sensing electrodes are 
separated in a 4-electrode configuration the detection of polarization would be 
avoided (such as in method described in transthoracic impedance 
measurements, Figure 1. However, in the 2-electrode measurement setup used 
in this thesis, there was no net charge to the test subject since the current used 
was truly bi-phasic. Therefore, the signal did not itself cause polarization. Also, 
the self polarization, i.e. the composition of different bio-materials and 
electrode materials in the electrochemical environment, is a slow process and 
such alteration of the total impedance should not cause any contribution in our 
frequency range of measurements. The electrode/tissue interface as such, must 
therefore be regarded as fairly stable and will not change the shape of the 
impedance pattern in the time scale important for this work.  
5.2 Observation of the notch 
The intracardiac impedance slope change is visually observed, using the 
averaged curve forms calculated as described in 2.3 on page 18. Of course, a 
computerized and automatic detection of notch is preferable but as the 
explanation and description of the notch has been prioritized in this thesis, no 
such detection algorithm has yet been developed.  
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The observation of notch is sometimes made more easily by using the 
standard deviation curve as described in Figure 5.1 below. 
 
 
 
 
Figure 5.1 The observation of notch is sometimes made more easily with the aid of 
standard deviation curve. 
5.3 The non-invasive O-wave 
Lababidi et al. did a thorough definition of all curve segments in the 
first derivative of non-invasive transthoracic impedance (dZ/dt) and its relation 
to phonocardiography (LABABIDI et al., 1970). In fact, most of the impedance 
cardiogram work refers to this particular document for interpretation of 
transthoracic impedance curve segments, Figure 1.10. Although KARNEGIS and 
KUBICEK, 1970, denotes this inflection in transthoracic diastolic impedance as 
the V-wave (and as V’ in the first derivative of transthoracic impedance) O-
wave is the overall dominating name. It seems that the transthoracic O-wave 
got its name from O-wave curve segment of the apex cardiogram, merely 
because they coincide in the heart cycle. It also seems that the fact that 
impedance O-wave coincide with mitral valve opening snap does not raise any 
doubtful questions as to whether the O-wave really is caused by mitral valve 
movements or not. In fact, the origin of the cardiac portion of transthoracic 
impedance (and therefore also the O-wave) is truly complex and not straight 
forward (KAUPPINEN, 1999). It is therefore not proven without doubt that 
transthoracic O-wave really is caused by intracardiac events. A clear 
explanation of origin of the O-wave in transthoracic impedance has been 
discussed by others (LABABIDI, 1978; RAMOS, 1977) but is yet to be found. 
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Prewitt et al. claim that the O-wave in apex cardiogram is not related to 
mitral valve movement. This work claim that it correlates more closely with 
the peak rate of outward wall movement in early rapid filling (PREWITT et al., 
1975). Their work does not involve impedance measurements at all, but is well 
worth mentioning here since it provides interesting theories on the true reason 
for the O-wave in the apex cardiogram, and therefore also for the transthoracic 
impedance O-wave. 
In 91 patients studied by Lababidi et al., 85.5 % displayed a visible O-
wave. In work by Mattar et al. 86% in 913 impedance tracings measured in 100 
patients displayed a visible O-wave (MATTAR et al., 1991). Lababidi et al. 
particularly studied the O-wave in transthoracic dZ/dt signal simultaneously 
with the apex cardiogram in 10 patients with mitral stenosis. In 6 of these 
specific patients, the impedance O-wave was exactly simultaneous with the 
opening of mitral valve, seen as the “maximal vibration of the 
phonocardiographic opening snap”. In the remaining 4 patients, the impedance 
O-wave was found within 10 ms.  
5.4 Notch intracardiac equivalent of transthoracic O-
wave 
One immediate and incorrect conclusion as to how the notch occurs is 
to say that it is simply the “atrial kick”, i.e. ventricular filling caused by atrial 
contraction. As shown in paper I, the notch occurs closely after rapid early 
filling (“E-wave” in mitral flow) but prior to ventricular filling caused by atrial 
contraction. A similar observation with the O-wave has also been made by 
PICKET and BUELL, 1993. In their work, O-wave and E/A waves are plotted 
simultaneously and the O-wave occurs closely at the time of the E-wave. 
Picket and Buell suggest that O-wave size correlates with E velocity (mitral 
blood flow at E-wave). The evidence that notch is seen closely after E-wave 
along with the fact that notch temporal position is before the P-wave in the 
ECG in all measurements, strongly indicates that impedance notch is caused by 
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early rapid ventricular filling and not by the atrial contraction. These results are 
supported by earlier apex cardiogram work in which it was concluded that the 
O-wave in the apex cardiogram is not related to mitral valve movement but 
more closely correlated with the peak rate of outward wall movement in early 
rapid filling PREWITT et al., 1975. One should point out here that the 
impedance in question is measured on the right side, and the mitral blood flow 
is detected on the left side of the heart. Skeptics might say that the opening of 
the tricuspid valve may be later compared to mitral valve opening, and thus 
that tricuspid valve opening has an important role of the origin of notch. As 
described in chapter 3.2 on page 23, in the majority of the cases the tricuspid 
valve opens 23.6 ms (standard deviation 24.4 ms) before mitral blood flow as 
indicated in analysis of first derivative of ventricular pressures. Also, by visual 
inspection of the signals, as seen in Figure 3.3, the notch occurs well after 
indication of opening of tricuspid and mitral valve. 
The notch described in the clinical data in paper I and II had similar 
features as the diastolic O-wave form in non-invasive transthoracic impedance 
data reported earlier with regards to timing and morphology. The results from 
paper I suggests that the notch is caused by ventricular wall movements due to 
the rapid early filling and not by the atrial kick. The origin of the intracardiac 
O-wave may possibly be an effect of ventricular wall movements caused by the 
rapid filling, a theory described by others (PREWITT et al., 1975) but surely, 
more studies need to be performed to clarify the origin of intracardiac O-wave. 
The time between R-wave in ECG and notch (normalized with regards to 
average heart cycle interval) versus heart rate varied exponentially, r2=0.95, 
illustrating that the notch temporal position is affected by heart rate and 
therefore also may be affected by ventricular filling. Bearing in mind that 
ventricular filling is faster during physical load due to higher venous pressure, 
the suggested theory in paper I also has support in the fact that timing of the 
notch is effected by heart rate in an exponential way as shown in paper II. One 
should point out, however, that the hemodynamical situation during drug 
induced increase of cardiac load in this study is not quite the same as in a 
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person who is walking or running in an upright position. In the latter case, 
venous return of blood to the heart is markedly increased. Even so, ventricular 
filling as seen with the notch is somehow affected by diastole as indicated by 
the notch timing versus heart rate. 
As described in Table 2, the occurrence of notch in paper II varies 
between 80-100 % depending on inter-electrode distance and group. As for the 
impedance measurements only performed during resting conditions, the notch 
occurrence is 100% for inter-electrode distance of 20 mm, whereas it is 90 % 
for 10 mm and 30 mm. In the group of patients undergoing drug-induced 
increase of cardiac work, no such differentiation can be seen. The reason for 
this behavior is unknown. 
In approximately 15 % of all subjects in this thesis do not present a 
visible notch and the reason for this can only be speculative at this point. 
Measurement lead tip location and ventricular apex anatomy may be important 
factors. 
5.5 Summary 
The intracardiac impedance notch in the present thesis has similar 
features with regards to temporal position as the non-invasive transthoracic 
impedance O-wave. The notch is observed in two different data sets; in animals 
and in humans and with different types of intracardiac leads (pacemaker leads 
in the pre-clinical study, paper I, and EP catheters in the clinical study, paper 
II). Several different physicians performed the lead implantation. The notch 
prevalence is well comparable with O-wave prevalence. With the consistent 
results from these two studies at hand, it can be shown that the diastolic 
intracardiac impedance notch is a characteristic of intracardiac impedance, and 
that it is a sensed physiological cardiac parameter of diastole. In addition, the 
notch has similar properties as the non-invasive O-wave. Since the present data 
is measured intracardically it can be concluded that the non-invasive O-wave in 
fact is caused by cardiac movements.   
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6 Future work  
In future work, intracardiac impedance will be studied simultaneously 
with state-of-the art echocardiography using the tissue velocity imaging (TVI) 
technique. In TVI, the ultrasonic wave reflection signal is filtered in such a 
way that the movement of cardiac tissue is at focus. The cardiac tissue velocity 
in varying points in the heart can therefore be studied in detail. This will be 
performed in animals and in humans in order to further explain the origin of the 
notch in myocardial tissue movements. 
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7 Conclusions 
The diastolic intracardiac impedance displays a consistent slope change 
called notch. The notch in the present study has similar features as the non-
invasive transthoracic impedance O-wave reported earlier. The notch 
occurrence was found to be well comparable with results in work with O-wave 
reported earlier. The notch was found closely after early rapid ventricular 
filling but before ventricular filling caused by atrial contraction, and it is 
concluded that the notch is not caused by atrial contraction. The notch is most 
likely caused by cardiac wall movements in rapid ventricular filling.  
The notch is observed in two different data sets; in animals and in 
humans and with different types of intracardiac leads. The lead implantation 
was performed by several different physicians. With the consistent results from 
these two studies at hand, this licentiate thesis concludes that the diastolic 
intracardiac impedance notch is a characteristic of intracardiac impedance, that 
the notch is the intracardiac equivalent of the non-invasive transthoracic 
impedance O-wave and that it is a sensed physiological cardiac parameter of 
diastole. 
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